McKinsey & BioEquity - BioTech Success in Europe, 2023

McKinsey & Company's report "Preparing a New Action Plan for Biotechnology Companies' Success in Europe"provides information on the biotechnology industry in Europe and how to succeed in this field. It covers four major issues related to the biotechnology industry, including the public market and financing, changes in industry structure, progress in Europe and future considerations for biotechnology companies and investors. The report also includes an overview of the methodology and an appendix. It is intended to provide information based on available data for consideration rather than specific recommendations. For more information, please refer to the report itself. The report analyzes the current state of the biotechnology industry in Europe, including its structure, financing and market. It also describes the changes that are taking place in the industry and forecasts how they may affect biotech companies and investors. The report also provides recommendations for biotechnology companies that want to succeed in Europe, including strategies for attracting investment and managing risk. The report also notes that the biotechnology industry in Europe continues to grow and develop despite some challenges, such as regulatory uncertainty and competition from other regions. However, the report warns that biotech companies must be prepared for changes in the industry and take measures to manage risks. Overall, the McKinsey & Company report provides valuable information for biotechnology companies and investors who are interested in the development of this industry in Europe. It contains an analysis of the current state of the industry, forecasts for the future and recommendations for success in this area.